Antimicrobial-resistant Shigella infections from Iran: an overlooked problem?

2012101 citationsJournal Articlebronze Open Access

Authors

Mercedeh Tajbakhsh · Shahid Beheshti University of Medical Sciences

L. Garcia Migura · Centre de Recerca en Sanitat Animal

Mohammad Rahbar · Iranian Institute for Health Sciences Research

Christina Aaby Svendsen · Technical University of Denmark

Mona Mohammadzadeh · Milad Hospital

Mohammad Reza Zali · Shahid Beheshti University of Medical Sciences

Frank M. Aarestrup

Abstract

This is the first known description of ESBL-producing and AmpC β-lactamase-producing Shigella and of PMQR Shigella in Iran. The emergence of CTX-15, CMY-2 and qnrS1 genes may compromise the treatment of shigellosis. Strategies to minimize the spread of ESBL-producing and AmpC-β-lactamase-producing Shigella should be implemented.

Topics & Keywords

Escherichia coli research studies Salmonella and Campylobacter epidemiology Antibiotic Resistance in Bacteria

UN Sustainable Development Goals

Life in Land

Publication Details

Published in: Journal of Antimicrobial Chemotherapy

Volume 67, Issue 5, pp. 1128-1133

DOI: 10.1093/jac/dks023

Field-Weighted Citation Impact: 4.68